NO995033D0 - 6,7-disubstituerte-4-aminopyrido[2,3-D]pyrimidinforbindelser - Google Patents

6,7-disubstituerte-4-aminopyrido[2,3-D]pyrimidinforbindelser

Info

Publication number
NO995033D0
NO995033D0 NO995033A NO995033A NO995033D0 NO 995033 D0 NO995033 D0 NO 995033D0 NO 995033 A NO995033 A NO 995033A NO 995033 A NO995033 A NO 995033A NO 995033 D0 NO995033 D0 NO 995033D0
Authority
NO
Norway
Prior art keywords
aminopyrido
disubstituted
pyrimidine
Prior art date
Application number
NO995033A
Other languages
English (en)
Other versions
NO995033L (no
Inventor
Shripad S Bhagwat
Chih-Hung Lee
Richard J Perner
Yu-Gui Gu
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO995033D0 publication Critical patent/NO995033D0/no
Publication of NO995033L publication Critical patent/NO995033L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
NO995033A 1997-04-16 1999-10-15 6,7-disubstituerte-4-aminopyrido[2,3-D]pyrimidinforbindelser NO995033L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83439397A 1997-04-16 1997-04-16
PCT/US1998/004127 WO1998046603A1 (en) 1997-04-16 1998-04-16 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds

Publications (2)

Publication Number Publication Date
NO995033D0 true NO995033D0 (no) 1999-10-15
NO995033L NO995033L (no) 1999-12-15

Family

ID=25266829

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995033A NO995033L (no) 1997-04-16 1999-10-15 6,7-disubstituerte-4-aminopyrido[2,3-D]pyrimidinforbindelser

Country Status (20)

Country Link
EP (1) EP0979230A1 (no)
JP (1) JP2001520649A (no)
KR (1) KR20010006453A (no)
CN (1) CN1259948A (no)
AR (1) AR012435A1 (no)
AU (1) AU744528B2 (no)
BG (1) BG103861A (no)
BR (1) BR9809088A (no)
CA (1) CA2287465A1 (no)
CO (1) CO4940439A1 (no)
HU (1) HUP0001402A3 (no)
IL (1) IL131892A0 (no)
NO (1) NO995033L (no)
NZ (1) NZ337844A (no)
PL (1) PL336262A1 (no)
SK (1) SK142099A3 (no)
TR (1) TR199902456T2 (no)
TW (1) TW458977B (no)
WO (1) WO1998046603A1 (no)
ZA (1) ZA982912B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001057040A1 (en) * 2000-02-03 2001-08-09 Abbott Laboratories 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
HU229604B1 (en) * 2001-02-12 2014-02-28 Hoffmann La Roche 6-substituted pyrido-pyrimidines, process for their preparation and pharmaceutical compositions containing them
WO2006053250A2 (en) 2004-11-12 2006-05-18 Trustees Of Tufts College Lipase inhibitors
US20100063032A1 (en) * 2007-03-28 2010-03-11 Debenham John S Substituted pyrido[2,3-d]pyrimidine derivatives as cannabinoid-1 receptor modulators
EA201590693A1 (ru) * 2012-10-05 2015-08-31 Ригель Фармасьютикалс, Инк. Ингибиторы gdf-8
US10016432B2 (en) 2016-05-27 2018-07-10 Legacy Emanuel Hospital & Health Center Methanocarba derivatives of pseudoribose that inhibit adenosine kinase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB774094A (en) * 1953-01-02 1957-05-08 Wellcome Found Improvements in or relating to pyrimidine compounds
IL112249A (en) * 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds

Also Published As

Publication number Publication date
CO4940439A1 (es) 2000-07-24
BG103861A (en) 2000-06-30
IL131892A0 (en) 2001-03-19
TR199902456T2 (xx) 2000-07-21
ZA982912B (en) 1998-10-09
AU744528B2 (en) 2002-02-28
CA2287465A1 (en) 1998-10-22
JP2001520649A (ja) 2001-10-30
CN1259948A (zh) 2000-07-12
NO995033L (no) 1999-12-15
KR20010006453A (ko) 2001-01-26
EP0979230A1 (en) 2000-02-16
NZ337844A (en) 2001-11-30
BR9809088A (pt) 2000-08-01
WO1998046603A1 (en) 1998-10-22
SK142099A3 (en) 2000-05-16
AR012435A1 (es) 2000-10-18
HUP0001402A3 (en) 2001-01-29
TW458977B (en) 2001-10-11
AU7098198A (en) 1998-11-11
HUP0001402A2 (hu) 2000-10-28
PL336262A1 (en) 2000-06-19

Similar Documents

Publication Publication Date Title
ID26698A (id) SENYAWA-SENYAWA PIROLO [2,3-d] PIRIMIDINA
NO20021694L (no) Pyrazolo[4,3-d]pyrimidinderivater
IS5721A (is) Pýróló [2,3-dl]pírimídín efnasambönd
DE69804273T2 (de) 5h-Thiazolo[3,2-a]pyrimidinderivate
NO20022738L (no) Pyrrolo(2,3-d)pyrimidinforbindelser
DE50001191D1 (de) Pyrazolo[4, 3-d]pyrimidine
ZA983177B (en) 5,7-Disubstituted-4-aminopyrdo [2,3] pyrimidine compounds
NO995033D0 (no) 6,7-disubstituerte-4-aminopyrido[2,3-D]pyrimidinforbindelser
NO995035D0 (no) 5,6,7-trisubstituerte-4-aminopyrido[2,3-D]pyrimidinforbindelser
DE69815072D1 (de) Substituierte 2,4-diaminopyrimidine

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application